Evidence map›Paper›PMID 31061006›Full record

ReviewMolecular pharmacology2019

Update on Gaseous Signaling Molecules Nitric Oxide and Hydrogen Sulfide: Strategies to Capture their Functional Activity for Human Therapeutics.

Nathan S Bryan, David J Lefer

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Molecular pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Bioenergetics and Reactive Nitrogen Species in Bacteria.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nathan S BryanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas (N.S.B.); and Louisiana State University School of Medicine, New Orleans, Louisiana (D.J.L.) Nathan.bryan@bcm.edu.
David J LeferDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas (N.S.B.); and Louisiana State University School of Medicine, New Orleans, Louisiana (D.J.L.).
Baylor College of Medicine · USLouisiana State University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Endogenous Hydrogen Sulfide Enzymes in Heart FailureR01HL146098 · NHLBI · LSU HEALTH SCIENCES CENTER · PI XIA, HUIJING · 2019 to 2022
$1.6M
Development of the PTP1B inhibitor MSI-1436 for therapeutic stimulation of heart regeneration following acute myocardial infarctionR44HL139161 · NHLBI · REVIDIA THERAPEUTICS, INC · PI YIN, VIRAVUTH P · 2017 to 2018
$1.5M
Development of Novel Adenosine Polymers for Coating Medical DevicesR44HL136233 · NHLBI · ADENOPAINT, LLC · PI FORMAN, MERVYN B. · 2017 to 2018
$1.3M
Novel Mitochondrial DNA Repair Enzyme for Heart FailureR44HL139195 · NHLBI · EXSCIEN CORPORATION · PI LEFER, DAVID JOSEPH, WILSON, GLENN · 2017 to 2017
$297k
NHLBI NIH HHS R01 HL146098NHLBI NIH HHS R44 HL136233NHLBI NIH HHS R44 HL139161NHLBI NIH HHS R44 HL139195NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Discovery of the production of gaseous molecules, such as nitric oxide and hydrogen sulfide, within the human body began a new concept in cellular signaling. Over the past 30 years, these molecules have been investigated and found to have extremely important beneficial effects in numerous chronic diseases. Gaseous signaling molecules that diffuse in three dimensions apparently contradict the selectivity and specificity afforded by normal ligand receptor binding and activation. This new concept has also created hurdles in the development of safe and efficacious drug therapy based on these molecules. Mechanisms involving formation of more stable intermediates and second messengers allow for new strategies for safe and effective delivery of these molecules for human disease. The purpose of this review is to highlight the biologic effects of nitric oxide and hydrogen sulfide, their seemingly indistinguishable effects, and how these molecules can be safely harnessed for drug development and precursors or substrates administered for human consumption through applied physiology.

Indexed as

Drug DevelopmentGene Regulatory NetworksHumansHydrogen SulfideNitric OxideSignal TransductionHydrogen SulfideNitric Oxide

Identifiers

PMID31061006
PMCPMC6592147
OpenAlexW2944220323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.